About OncoLens

OncoLens is a healthcare technology company based in Atlanta, specializing in an AI-enabled digital platform designed to enhance multidisciplinary cancer care and treatment planning. Founded by Anju Mathew and Dr. Lijo Simpson, the company aims to alleviate administrative burdens in oncology by combining advanced technology with expert knowledge. OncoLens serves over 225 cancer centers across the US and internationally, impacting more than 5 million oncology patients.

The platform offers a range of HIPAA-compliant solutions that focus on data interoperability and collaboration among healthcare professionals. Key features include Virtual Tumor Board management, integration of molecular and genomic data for targeted treatment planning, and AI-powered patient identification for clinical trials. OncoLens also provides clinical decision support tools that align with established guidelines and facilitate personalized patient care. The company has achieved significant milestones, including SOC 2 Certification and recognition on the Inc. 5000 list of fastest-growing private companies.